{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-076515","form_type":"8-K","ticker":"SXTP","cik":"0001946563","company_name":"60 DEGREES PHARMACEUTICALS, INC.","filed_at":"2024-09-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:15.252338+00:00","generated_at":"2026-05-31T06:07:35.184562+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"60 Degrees Pharmaceuticals raises ~$4M in private placement of common stock equivalents and warrants","bullets":["Issued 2,898,551 pre-funded warrants and series A/B warrants at $1.38/share for gross proceeds of ~$4M.","Placement closed Sept. 5, 2024; H.C. Wainwright acted as exclusive placement agent.","Net proceeds to fund working capital, Arakoda commercialization, and R&D programs.","Warrants exercisable upon stockholder approval; Series A expire 5 years, Series B expire 18 months thereafter."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-076515","json":"https://secwatch.observer/filing/0001213900-24-076515.json","markdown":"https://secwatch.observer/filing/0001213900-24-076515.md","text":"https://secwatch.observer/filing/0001213900-24-076515.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1946563/000121390024076515/0001213900-24-076515-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1946563/000121390024076515/ea0213757-8k_60degrees.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T06:07:35.184562+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}